The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global nebulizers market reached a value of US$ 1.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2027, exhibiting a CAGR of 7.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Nebulizers are devices that are used by patients suffering from respiratory diseases to administer the medication directly into the lungs. Usually made up of a motor, mouthpiece, cup and tubing, these devices turn liquid medicine into a fine mist by using oxygen, compressed air or ultrasonic power for breaking up the liquid drug into aerosols. They are prescribed by doctors to people who are unable to breathe deeply while using an inhaler. Nebulizers are primarily utilized for providing relief from extreme breathing conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, etc.
Rising prevalence of chronic respiratory diseases is a major factor boosting the growth of the market. Busy schedules, sedentary lifestyles and a lack of physical activities have led to an increase in prevalence of obesity across the globe. This, in confluence with escalating consumption of tobacco and alcohol, is significantly contributing to the increasing occurrence of respiratory disorders, thereby bolstering the sales of nebulizers. Apart from this, rising pollution levels on account of increasing adoption of private vehicles and expansion of industries is another key factor that is contributing to the product’s demand globally. Moreover, the growing geriatric population has led to an increase in the demand for home healthcare devices, which is driving the demand for portable variants. Furthermore, several organizations are taking initiatives to spread awareness about the available treatment options for respiratory diseases. For instance, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) is actively educating the public about the risks posed by COPD and the treatment of the same.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nebulizers market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product type, portability, end-user and application.
Breakup by Product Type:
Breakup by Portability:
Breakup by End-User:
Breakup by Application:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc. and Graham Field (GF) Health Products, Inc., etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Portability, End-User, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Companies Covered||Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc. and Graham Field (GF) Health Products, Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at